NCT01905813 2025-12-19
Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies
Incyte Corporation
Phase 1 Active not recruiting
Clinical Trials
3 trialsNCT04170283 2025-10-21
Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Participants With B-cell Malignancies
BeOne Medicines
Phase 3 Active not recruiting
NCT02457598 2025-06-17
Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therapies in Adults With B-cell Malignancies
Gilead Sciences
Phase 1 Terminated